Childhood Hodgkin Lymphoma Treatment (PDQ®): Treatment - Patient Information [NCI]-Treatment Options

109 24
Childhood Hodgkin Lymphoma Treatment (PDQ®): Treatment - Patient Information [NCI]-Treatment Options for Primary Refractory / Recurrent Hodgkin Lymphoma in Children and Adolescents Treatment of primary refractory or recurrent childhood Hodgkin lymphoma may include the following:
  • Chemotherapy, monoclonal antibody therapy, or a combination of these therapies.
  • High-dose chemotherapy with stem cell transplant using the patient's own stem cells. Low-dose radiation therapy also may be given after transplant.
  • High-dose chemotherapy with stem cell transplant using a donor's stem cells.
  • A clinical trial of a new combination of a monoclonal antibody and chemotherapy.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent/refractory childhood Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.

Recommended Related to Cancer



General Information About Vaginal Cancer

Incidence and MortalityEstimated new cases and deaths from vaginal (and other female genital) cancer in the United States in 2014:[1] New cases: 3,170. Deaths: 880. Carcinomas of the vagina are uncommon tumors comprising about 1% of the cancers that arise in the female genital system.[1,2]Early stage tumors are often curable with local modality therapies, but there is no standard treatment of proven efficacy for metastatic disease. A large proportion (30%-50%) of women with...

Read the General Information About Vaginal Cancer article > >

In this article

Source...
Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.